JRSIS HEALTH CARE Corp (JRSS) Financial Statements (2023 and earlier)

Company Profile

Business Address 3/F BUILDING A, DERUN YUAN
WUGUISHAN, ZHONGSHAN CITY, 528458
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 806 - Hospitals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5911381,947856528313
Cash and cash equivalents5911381,947856528313
Receivables43178,8497,8829,1586,822
Inventory, net of allowances, customer advances and progress billings   1,7451,7711,7451,178
Inventory   1,7451,7711,7451,178
Prepaid expense   4,2142,812 996
Deferred costs736818900399461454457
Other undisclosed current assets    84270273
Total current assets:79983295517,15413,86612,15410,040
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization     16,52014,860
Operating lease, right-of-use asset 2227  3,7113,967
Property, plant and equipment39404534,37933,16332,48332,028
Deposits noncurrent assets   970968953581
Deferred costs   2,0652,1182,2002,300
Other undisclosed noncurrent assets18  26,59725,5782,9751,438
Total noncurrent assets:57617164,01161,82758,84255,173
TOTAL ASSETS:8568941,02681,16575,69370,99665,213
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities27111118,47715,39111,97710,579
Taxes payable967421 564
Employee-related liabilities121,0871,0591,1641,123
Accounts payable258814,36912,43210,8128,892
Accrued liabilities2122,0541,479  
Debt   631629280389
Due to related parties 2 3711,534100
Other liabilities   76   
Other undisclosed current liabilities1715151,0561,5783,9113,285
Total current liabilities:43282620,27717,60017,70114,353
Noncurrent Liabilities
Long-term debt and lease obligation161020,66520,99818,03816,753
Long-term debt, excluding current maturities   618617607607
Finance lease, liability161020,04620,38117,43116,145
Liabilities, other than long-term debt   4,2743,9933,8063,201
Deferred income tax liabilities   4,2743,9933,8063,201
Other undisclosed noncurrent liabilities    038
Total noncurrent liabilities:161024,93924,99121,84719,961
Total liabilities:45333745,21542,59139,54834,314
Equity
Equity, attributable to parent81186198924,06422,06820,82920,453
Common stock58585819191919
Additional paid in capital24,45324,45324,45323,38123,38123,38123,381
Accumulated other comprehensive income6106695545176169
Accumulated deficit(23,706)(23,660)(23,528)(30)(1,877)(2,747)(3,116)
Equity, attributable to noncontrolling interest   11,88511,03410,61910,446
Total equity:81186198935,94933,10231,44830,899
TOTAL LIABILITIES AND EQUITY:8568941,02681,16575,69370,99665,213

Income Statement (P&L) ($ in thousands)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Revenues89  15,61913,16512,15911,741
Cost of revenue
(Cost of Goods and Services Sold)
   (1,101)(864)(838)(804)
Gross profit:   14,51912,30211,32110,937
Operating expenses26(219)(133)(12,045)(11,958)(11,424)(10,308)
Other undisclosed operating income (loss)(70)8661,101886838804
Operating income (loss):(44)(132)(127)3,5741,2307341,433
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
   (7)304(1)(33)
Interest and debt expense   (407)(305)(345)(441)
Other undisclosed loss from continuing operations before equity method investments, income taxes(2)      
Income (loss) from continuing operations before equity method investments, income taxes:(46)(132)(127)3,1611,229389959
Other undisclosed income from continuing operations before income taxes   407305345441
Income (loss) from continuing operations before income taxes:(46)(132)(127)3,5671,5347341,400
Income tax expense   (928)(406)(192)(377)
Income (loss) from continuing operations:(46)(132)(127)2,6391,1285411,023
Income (loss) before gain (loss) on sale of properties:(132)(36,182)2,6391,1285411,023
Loss from discontinued operations  (36,055)    
Net income (loss):(46)(132)(36,182)2,6391,1285411,023
Net income (loss) attributable to noncontrolling interest  34,985(792)(259)(173)(357)
Other undisclosed net income attributable to parent36,055 1,070792957173357
Net income (loss) attributable to parent:36,009(132)(127)2,6391,8265411,023
Other undisclosed net loss available to common stockholders, basic   (792)(957)(173)(357)
Net income (loss) available to common stockholders, diluted:36,009(132)(127)1,847870369666

Comprehensive Income ($ in thousands)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Net income (loss):(46)(132)(36,182)2,6391,1285411,023
Other undisclosed comprehensive income (loss)(4)4111    
Comprehensive income (loss):(49)(129)(36,071)2,6391,1285411,023
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  34,985(851)(415)(173)(497)
Other undisclosed comprehensive income, net of tax, attributable to parent34,985  2085267472
Comprehensive income (loss), net of tax, attributable to parent:34,935(129)(1,086)1,9961,239376997

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: